HIMS Stock Summary and Trading Ideas (Hims & Hers Health Class A | NYSE:HIMS)

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

What symbol and exchange does Hims & Hers Health Class A shares trade?

Hims & Hers Health Class A trades on the NYSE stock market under the symbol HIMS.

What is Hims & Hers Health Class A stock price doing today?

As of February 9, 2026, HIMS stock price declined to $19.33 with 131,323,907 million shares trading.

What is Hims & Hers Health Class A's Beta?

HIMS has a beta of 1.86, meaning it tends to be more sensitive to market movements. HIMS has a correlation of 0.10 to the broad based SPY ETF.

How much is Hims & Hers Health Class A worth?

HIMS has a market cap of $4.40 billion. This is considered a Mid Cap stock.

How much money does Hims & Hers Health Class A make?

Last quarter Hims & Hers Health Class A reported $599 million in Revenue and $.09 earnings per share. This beat revenue expectation by $18 million and missed earnings estimates by -$.01.

What is the highest and lowest price Hims & Hers Health Class A traded in the last 3 year period?

In the last 3 years, HIMS traded as high as $72.98 and as low as $5.65.

What are the top ETFs holding Hims & Hers Health Class A?

The top ETF exchange traded funds that HIMS belongs to (by Net Assets): VTI, IJH, VB, IWM, VBK.

Is Hims & Hers Health Class A (HIMS) a good investment?

HIMS has underperformed the market in the last year with a price return of -52.2% while the SPY ETF gained +15.7%. HIMS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -53.4% and -34.7%, respectively, while the SPY returned +3.8% and +0.7%, respectively.

What are the support and resistance levels for Hims & Hers Health Class A (HIMS)?

HIMS support price is $21.70 and resistance is $24.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HIMS shares will trade within this expected range on the day.